In vivo functional interaction between phencyclidine binding sites and σ receptors to produce head-weaving behavior in rats

European Journal of Pharmacology

Volumn 318, Issue 2-3, 1996, Pages 205-211

  Kitaichi, Kiyoyuki ^a   Noda, Yukihiro ^a   Hasegawa, Takaaki ^a   Furukawa, Hiroshi ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Receptor; Dizocilpine; Head weaving behavior; Phencyclidine (PCP) receptor; Rat

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; DIZOCILPINE; N ALLYLNORMETAZOCINE; PHENCYCLIDINE; PHENCYCLIDINE RECEPTOR; PRECLAMOL; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANISOLES; BEHAVIOR, ANIMAL; BINDING SITES; DIZOCILPINE MALEATE; GUANIDINES; MALE; PHENAZOCINE; PIPERIDINES; PROPYLAMINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, PHENCYCLIDINE; RECEPTORS, SIGMA;

EID: 0030607667     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00771-6     Document Type: Article

References (33)

1. Balster, R.L., 1987, The behavioral pharmacology of phencyclidine, in: Psychopharmacology: The Third Generation of Progress, ed. H.Y. Meltzer (Raven Press, New York, NY) p. 1573.
2. Brent, P.J., 1991, Similar behavioral effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs, Psychopharmacology 104, 421.
3. 1 binding sites in guinea pig brain, Eur. J. Pharmacol. 251, R1.
4. 2 receptor in rat brain, Mol. Pharmacol. 42, 471.
5. Graybiel, A.M., M.J. Besson and E. Weber, 1989, Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma site in the substantia nigra, pars compacta of the rat, J. Neurosci. 9, 326.
6. 3H-(+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, J. Neurosci. 6, 1757.
7. Hellewell, S.B. and W.D. Bowen, 1990, A sigma-like binding site in rat pheochrocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res. 527, 244.
8. Hiramatsu, M., T. Nabeshima, H. Furukawa and T. Kameyama, 1987, Different effects of ethylketocyclazocine on phencyclidine-and N-allylnormetazocine-induced stereotyped behaviors in rats, Pharmacol. Biochem. Behav. 28, 489.
9. Hiramatsu, M., A.K. Cho and T. Nabeshima, 1989, Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine, Eur. J. Pharmacol. 166, 359.
10. Javitt, D.C. and S.R. Zukin, 1991, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry 148, 1301.
11. Kitaichi, K., K. Yamada, T. Hasegawa, H. Furukawa and T. Nabeshima, 1994, Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin, Jpn. J. Pharmacol. 66, 181.
12. 3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine, Proc. Natl. Acad. Sci. USA 81, 4983.
13. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine, J. Pharmacol. Exp. Ther. 238, 739.
14. Löscher, W. and D. Hönack, 1992, The behavioral effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems, Eur. J. Pharmacol. 215, 199.
15. Manallack, D.T., P.M. Beart and A.L. Gundlach, 1986, Psychotomimetic σ-opiates and PCP, Trends Pharmacol. Sci. 7, 448.
16. Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppler and P.E. Gillbert, 1976, The effects of morphine and morphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197, 517.
17. 3 dorsal hippocampus by sigma ligands, J. Pharmacol. Exp. Ther. 261, 123.
18. 3H]-3-(-3-hydroxyphenyl)-N-(1-propyl) piperidine, Mol. Pharmacol. 35, 1.
19. Nabeshima, T. and S. Okuyama, 1994, Physiological function of sigma receptors: central pharmacological effects of sigma ligands, Jpn. J. Psychopharmacol. 14, 51.
20. Nabeshima, T., K. Yamada, K. Yamaguchi, M. Hiramatsu, H. Furukawa and T. Kameyama, 1983, Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats, Eur. J. Pharmacol. 91, 455.
21. 2 receptor, but not serotonin, receptor, Res. Commun. Subst. Abuse 5, 81.
22. Nabeshima, T., H. Fukaya, K. Yamaguchi, K. Ishikawa, H. Furukawa and T. Kameyama, 1987a, Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine, Eur. J. Pharmacol. 135, 23.
23. Nabeshima, T., K. Yamaguchi, K. Ishikawa, H. Furukawa and T. Kameyama, 1987b, Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats, J. Pharmacol. Exp. Ther. 243, 113.
24. Okuyama, S., Y. Imagawa, S. Ogawa, H. Araki, A. Ajima, M. Tanaka, M. Muramatsu, A. Nakazato, K. Yamaguchi, M. Yoshida and S. Otomo, 1993, NE-100, a novel sigma receptor ligand: in vivo tests, Life Sci. 53, PL285.
25. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.-P. Su, S.T. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
26. Reid, A.A., M.V. Mattson, B.R. De Costa, A. Thurkauf, A.E. Jacobson, J.A. Monn, K.C. Rice and R.B. Rothman, 1990, Specificity of phencyclidine-like drugs and benzomorphan opiates for two high affinity phencyclidine binding sites in guinea pig brain, Neuropharmacology 29, 811.
27. Sonders, M.S., J.F.W. Keana and E. Weber, 1988, Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action, Trends Neurosci. 11, 37.
28. 3H]haloperidol binding in guinea pig brain membranes, Proc. Natl. Acad. Sci. USA 81, 5618.
29. Taylor, D.P., M.S. Eison, S.L. Moon, R.F. Schlemmer. U.A. Shukla, C.P. Vander Maelem, F.D. Yocca, D.J. Gallant, S.W. Behling, C.G. Boissard, J.P. Braselton, H.H. Davis, M.N. Duquette, R.G. Lamy, J.M. Libera, E. Ryan and R.N. Wright, 1992, in: Sigma, PCP and NMDA Receptor Systems, eds. E.B. DeSouza and D.H. Clouet (National Institute of Drug Abuse Research Monograph, United States Government Printing Office, Washington, DC).
30. Ujike, H., K. Okumura, Y. Zushi, K. Akiyama and S. Otsuki, 1992, Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment, Eur. J. Pharmacol. 211, 323.
31. Yamaguchi, K., T. Nabeshima and T. Kameyama, 1986, Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors, J. Pharmacobio-Dyn. 9, 987.
32. 1 site, J. Neurosci. 15, 731.
33. 3H]TCP binding to intact primary cultured neuronal cells, Life Sci. 56, PL39.